Literature DB >> 24270416

Tuning mTOR activity for immune balance.

Kai Yang, Hongbo Chi.   

Abstract

The mTOR pathway orchestrates diverse physiological processes, including T cell functions and fate decisions; however, the regulation of mTOR-dependent T cell differentiation remains elusive. In this issue, Park et al. examine the role of TSC1, an mTOR signaling regulator, in T cell differentiation and the balance between T cell-mediated immunity and tolerance. They found that enhanced mTOR activity in Tsc1-deficient T cells promotes Th1 and Th17 differentiation, leading to increased intestinal inflammation in murine colitis. Tsc1-deficient Tregs had impaired suppressive activity in inflammatory conditions. These defects were associated with the acquisition of effector-like phenotypes and could be further exacerbated by concomitant loss of transcription factor Foxo3. This study highlights that TSC1-mediated control of mTOR activity impinges on the balance between immunity and tolerance by dictating effector and regulatory T cell responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24270416      PMCID: PMC3859402          DOI: 10.1172/JCI73202

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells.

Authors:  Weiming Ouyang; Omar Beckett; Qian Ma; Ji-hye Paik; Ronald A DePinho; Ming O Li
Journal:  Nat Immunol       Date:  2010-05-13       Impact factor: 25.606

2.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.

Authors:  Greg M Delgoffe; Thomas P Kole; Yan Zheng; Paul E Zarek; Krystal L Matthews; Bo Xiao; Paul F Worley; Sara C Kozma; Jonathan D Powell
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

3.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

4.  Activation of a metabolic gene regulatory network downstream of mTOR complex 1.

Authors:  Katrin Düvel; Jessica L Yecies; Suchithra Menon; Pichai Raman; Alex I Lipovsky; Amanda L Souza; Ellen Triantafellow; Qicheng Ma; Regina Gorski; Stephen Cleaver; Matthew G Vander Heiden; Jeffrey P MacKeigan; Peter M Finan; Clary B Clish; Leon O Murphy; Brendan D Manning
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

5.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.

Authors:  Keunwook Lee; Prathyusha Gudapati; Srdjan Dragovic; Charles Spencer; Sebastian Joyce; Nigel Killeen; Mark A Magnuson; Mark Boothby
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

6.  The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells.

Authors:  Qi Wu; Yu Liu; Chong Chen; Tsuneo Ikenoue; Yu Qiao; Chi-Shan Li; Weiquan Li; Kun-Liang Guan; Yang Liu; Pan Zheng
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

7.  The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.

Authors:  Peggy P Hsu; Seong A Kang; Jonathan Rameseder; Yi Zhang; Kathleen A Ottina; Daniel Lim; Timothy R Peterson; Yongmun Choi; Nathanael S Gray; Michael B Yaffe; Jarrod A Marto; David M Sabatini
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

8.  Foxo transcription factors control regulatory T cell development and function.

Authors:  Yann M Kerdiles; Erica L Stone; Daniel R Beisner; Daniel L Beisner; Maureen A McGargill; Irene L Ch'en; Christian Stockmann; Carol D Katayama; Stephen M Hedrick
Journal:  Immunity       Date:  2010-12-14       Impact factor: 31.745

9.  The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.

Authors:  Greg M Delgoffe; Kristen N Pollizzi; Adam T Waickman; Emily Heikamp; David J Meyers; Maureen R Horton; Bo Xiao; Paul F Worley; Jonathan D Powell
Journal:  Nat Immunol       Date:  2011-02-27       Impact factor: 25.606

10.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Authors:  Xuyu Zhou; Samantha L Bailey-Bucktrout; Lukas T Jeker; Cristina Penaranda; Marc Martínez-Llordella; Meredith Ashby; Maki Nakayama; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-07-26       Impact factor: 25.606

View more
  6 in total

Review 1.  Determinants of IBD Heritability: Genes, Bugs, and More.

Authors:  Williams Turpin; Ashleigh Goethel; Larbi Bedrani; Kenneth Croitoru Mdcm
Journal:  Inflamm Bowel Dis       Date:  2018-05-18       Impact factor: 5.325

Review 2.  Intersection of mTOR and STAT signaling in immunity.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Trends Immunol       Date:  2014-11-15       Impact factor: 16.687

3.  Tsc1 expression by dendritic cells is required to preserve T-cell homeostasis and response.

Authors:  Yuechen Luo; Wenwen Li; Gang Yu; Juan Yu; Ling Han; Ting Xue; Zhina Sun; Song Chen; Chunming Fang; Chunxiao Zhao; Qing Niu; Fei Yang; Zhongchao Han; Tao Cheng; Yun Zeng; Fang Liao; Guogang Xu; Xiaoming Feng
Journal:  Cell Death Dis       Date:  2017-01-12       Impact factor: 8.469

4.  Raptor/mTORC1 Acts as a Modulatory Center to Regulate Anti-bacterial Immune Response in Rockfish.

Authors:  Kang Li; Xiumei Wei; Libin Zhang; Heng Chi; Jialong Yang
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

5.  Glucocorticoids Promote the Onset of Acute Experimental Colitis and Cancer by Upregulating mTOR Signaling in Intestinal Epithelial Cells.

Authors:  Zhengguo Zhang; Lin Dong; Anna Jia; Xi Chen; Qiuli Yang; Yufei Wang; Yuexin Wang; Ruichen Liu; Yejin Cao; Ying He; Yujing Bi; Guangwei Liu
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

Review 6.  Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.

Authors:  Jing Jin; Qijie Zhao
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.